Founded in 2019 and based in Philadelphia, BioAlert Technologies's mission is develop methodologies to detecting infection in real-time. We are a developmental stage medical device company dedicated to the design and development of continuous infection monitoring (CIM) systems for diabetic foot ulcer patients. BioAlert Technologies enables healthcare providers to make diagnosis and treatment decisions based off of reliable data metrics.
Company Details
- Founded
- -
- Address
- 220 S 33rd St, Philadelphia,pennsylvania,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.bioalerttech.com
- HQ
- Philadelphia, Pennsylvania
Bioalert Technologies Questions
Bioalert Technologies's website is http://www.bioalerttech.com
Bioalert Technologies's LinkedIn profile is https://www.linkedin.com/company/bioalert-technologies
Bioalert Technologies's industry is
Medical Equipment Manufacturing
Bioalert Technologies's top competitors are
Llr Partners,
Autotab,
Unitree Robotics,
Squindo,
Prysm Capital,
United Soccer League (Usl),
Owkin,
Texas Disposal Systems,
Md Health,
Monomoy Capital Partners.
Bioalert Technologies's categories are Medical Equipment Manufacturing
Bioalert Technologies's founding year is 2019
